Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (411-420 of 466) with videos related to

Pageof 47
Sort By:
Oncogene|May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3GG Posern, J Zheng, B S Knudsen, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 26, 2008
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settingsBeatrice S Knudsen, Ping Zhao, James Resau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2020
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor ActivityShipra Gandhi, Manu R Pandey, Kristopher Attwood, et al.
American Heart Journal|October 24, 2008
Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter studyMorten Schou, Finn Gustafsson, Lars Videbaek, et al.
Oncogene|March 17, 2009
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.
Pageof 47

Showing results (411-420 of 466) with videos related to

Sort By:
Pageof 47
Oncogene|May 20, 1998
Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3GG Posern, J Zheng, B S Knudsen, et al.
Oncogene|May 16, 2022
TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in miceSamera H Hamad, Stephanie A Montgomery, Jeremy M Simon, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Communications Biology|October 1, 2024
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineagesMelanie R Walker, Alexander Underwood, Kasper H Björnsson, et al.
Oncotarget|May 6, 2015
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesisMathew C Casimiro, Gabriele Di Sante, Marco Crosariol, et al.
Oncogene|March 8, 2018
Regulation of inside-out β1-integrin activation by CDCP1Sara G Pollan, Fangjin Huang, Jamie M Sperger, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|September 26, 2008
A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settingsBeatrice S Knudsen, Ping Zhao, James Resau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2020
Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor ActivityShipra Gandhi, Manu R Pandey, Kristopher Attwood, et al.
American Heart Journal|October 24, 2008
Design and methodology of the NorthStar Study: NT-proBNP stratified follow-up in outpatient heart failure clinics -- a randomized Danish multicenter studyMorten Schou, Finn Gustafsson, Lars Videbaek, et al.
Oncogene|March 17, 2009
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcomeE K A Millar, J L Dean, C M McNeil, et al.
Pageof 47